PW Medtech Group (FRA:PWE) EPS (Basic): €0.01 (TTM As of Dec. 2025)


FRA:PWE PW Medtech Group Ltd FRA:PWE
82 GF Score
Price €0.11
GF Value €0.13
! 5 Warning Signs
View Full Analysis

What is PW Medtech Group EPS (Basic)?

PW Medtech Group FRA:PWE 82 EPS (Basic) is €0.01 as of Dec. 2025. GuruFocus rates FRA:PWE with a GF Score™ of 82/100 and a GF Value™ of €0.13. The stock has 5 warning signs investors should review.

PW Medtech Group's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was €0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.01.

PW Medtech Group's EPS (Diluted) for the six months ended in Dec. 2025 was €0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.01.

PW Medtech Group's EPS without NRI for the six months ended in Dec. 2025 was €0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 0.01.

During the past 12 months, PW Medtech Group's average EPS without NRIGrowth Rate was -32.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -4.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was -15.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, PW Medtech Group's highest 3-Year average EPS without NRI Growth Rate was 87.60% per year. The lowest was -42.00% per year. And the median was -3.00% per year.


PW Medtech Group  (FRA:PWE) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


PW Medtech Group EPS (Basic) Related Terms


PW Medtech Group EPS (Basic) Historical Data

* Premium members only.

The historical data trend for PW Medtech Group's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PW Medtech Group EPS (Basic) Chart

PW Medtech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.01 0.01 0.01 0.01

PW Medtech Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.00
FRA:PWE
82GF Score
PW Medtech Group Ltd FRA:PWE
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PW Medtech Group EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

PW Medtech Group's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(11.443-0)/1510.882
=0.01

PW Medtech Group's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3.441-0)/1535.029
=0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €0.01 mean?
PW Medtech Group (FRA:PWE) has a EPS (Basic) of €0.01 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on PW Medtech Group and its competitors.
Is PW Medtech Group's EPS (Basic) too high?
PW Medtech Group's current EPS (Basic) is €0.01. Overall, PW Medtech Group has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's EPS (Basic) compare to ISRG and BDX?
PW Medtech Group's EPS (Basic) of €0.01 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on PW Medtech Group and its competitors. PW Medtech Group's current EPS (Basic) is €0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
PW Medtech Group (FRA:PWE) has a current EPS (Basic) of €0.01. The stock's GF Value™ is €0.13, compared to a current price of €0.11 — trading 13.8% below its estimated fair value. The current EPS (Basic) is €0.01. PW Medtech Group's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current EPS (Basic) is €0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PW Medtech Group (FRA:PWE) Overvalued in 2026?

Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued. The current stock price of €0.11 is trading 13.8% below its estimated GF Value™ of €0.13.

Key valuation signals for FRA:PWE:

  • EPS (Basic): €0.01
  • GF Value™: €0.13 vs. price of €0.11 (13.8% below fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PW Medtech Group Business Description

Other Exchanges 01358:Hong Kong
Address No. 23 Panlong West Road, Building 1, Pinggu District, Beijing, CHN, 101204
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
82GF Score

Get the complete analysis for FRA:PWE

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.11
Price
€0.13
GF Value